Target intelligence / Profile preview

Fungal and yeast surface antigens

Molecular classification
Polysaccharide, Glycoprotein, Cell wall component, Surface protein
01

Overview

Fungal and yeast surface antigens represent a heterogeneous collection of molecules, primarily located within the complex cell wall, that serve as the primary interface between the fungal pathogen and the host immune system (Erwig & Gow, 2016). These antigens include essential structural components such as (1,3)-beta-D-glucan, chitin, and various mannoproteins, which are critical for maintaining cell wall integrity and mediating adhesion to host tissues (Brown, 2006). In the context of infectious diseases, these surface molecules are recognized by pattern recognition receptors (PRRs) on host immune cells, such as Dectin-1, triggering inflammatory responses and phagocytosis (Erwig & Gow, 2016). Therapeutically, these antigens are targeted by several classes of antifungal agents; for instance, the echinocandin class (e.g., caspofungin) specifically inhibits the synthesis of beta-glucan, leading to osmotic instability and cell death (Denning, 2003). Additionally, surface antigens serve as critical diagnostic biomarkers, such as the galactomannan assay used for detecting invasive aspergillosis, and are active areas of research for the development of monoclonal antibodies and vaccines aimed at enhancing the host's ability to clear fungal infections (Maertens et al., 2005; Perfect, 2017).

Other names
Fungal cell wall antigensYeast surface proteinsMycological cell surface markersFungal surface molecules
02

Mechanism of action

Inhibition of (1,3)-beta-D-glucan synthase; antibody-mediated opsonization and phagocytosis; disruption of cell wall structural integrity.

03

Biological functions

Cell wall organizationAdhesionImmune modulationPathogenesisBiofilm formation
04

Disease associations

InfectionCandidiasisAspergillosisCryptococcosisPneumocystis pneumoniaMycosis
05

Safety considerations

Infusion-related reactionsHepatotoxicityEmergence of resistance (e.g., FKS mutations)Potential cross-reactivity with host tissues
06

Interacting drugs

Caspofungin

4 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BDG)Galactomannan (GM)Cryptococcal antigen (CrAg)Mannan-binding lectin

Beyond the preview

Go deeper on Fungal and yeast surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal and yeast surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call